GeneMatrix develops and sells medical diagnostic reagents for disease diagnosis using its own proprietary technology,
also develops vaccines and immunotherapeutic agents for cancer treatment for disease prevention and treatment.
Diagnostic
Molecular Diagnostics
GeneMatrix provides high-performance multiplex molecular diagnostic kits for the diagnosis of infectious diseases based on its proprietary multiplexing technology.
We are committed to developing innovative products and strive to lead the global in the qPCR diagnostic market.
- Development of qPCR diagnostic kits for infectious diseases,
covering areas such as respiratory diseases, women's health, and sexual health. - R&D focused on Multiplex Real-time PCR
- Academic support for quantitative, high-quality infections disease qPCR testing
New Therapeutics Development
New Therapeutics Development
GeneMatrix has a passion for new therapeutics and a dedicated effort to the development of vaccines in the areas of infectious diseases and cancer. We are conducting research and development based on our patented viral vector technology and are continuing research and develop innovative vaccines through joint research with various partners.
- GeneMatrix has a pipeline consisting of 6 vaccines
- GeneMatrix conducts joint research projects with competitive domestic and foreign research institutes
- GeneMatrix has established technology platforms to expand research capabilities
